tradingkey.logo

Anika Therapeutics Inc <ANIK.OQ> expected to post a loss of 1 cent a share - Earnings Preview

ReutersMar 10, 2025 8:26 PM
  • Anika Therapeutics Inc ANIK.OQ ANIK.O is expected to show a fall in quarterly revenue when it reports results on March 12 for the period ending December 31 2024

  • The Bedford Massachusetts-based company is expected to report a 32.5% decrease in revenue to $29 million from $42.97 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Anika Therapeutics Inc is for a loss of 1 cent per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Anika Therapeutics Inc is $26.50​, above​ its last closing price of $16.62. ​​​

This summary was machine generated March 10 at 20:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI